Generic Dacomitinib for EGFR-mutated NSCLC

So, Dacomitinib is this EGFR inhibitor thing, and it’s used for a type of lung cancer called NSCLC. It’s especially for folks with those EGFR exon 19 deletions or L858R mutations. The drug works by stopping EGFR signaling.

You can get it in tablet form, and it comes in different strengths: 15 mg, 30 mg, and the most common one is 45 mg. They usually recommend taking 45 mg a day. It comes in bottles, and each one has 30 tablets.

It’s like a generic version of Tagrisso, which is that expensive brand-name drug. It’s cheaper and still does the trick.